Funded Tech Companies
Apollo Therapeutics
Apollo Therapeutics is a biopharmaceutical venture, based in Cambridge, England. Financial backing was provided by Rock Springs Capital, M&G Investments and Patient Square Capital.
Company Overview
Company Name
Apollo Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3rd Floor 22 Station Road
Cambridge, England, CB1 2JD
UK
Cambridge, England, CB1 2JD
UK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Apollo Therapeutics is a biopharmaceutical company rapidly advancing a robust pipeline of potentially transformative therapeutic programs based on breakthrough discoveries. Through deep relationships with world-leading universities and scientists, the company identifies programs with strong biological hypotheses and potential to become meaningful new treatment options. Apollo's portfolio-based model combines a centralized team of drug development 'architects' and subject matter experts who are able to rigorously evaluate therapeutic programs in an objective, data-driven manner -- prioritizing critical experiments to de-risk programs early. This capital efficiency allows Apollo to focus on scaling a robust and potentially transformative pipeline, with over 15 therapeutic programs in development today across oncology, major inflammatory disorders and rare disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/2/2024
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Mason
Chief Financial Officer
Jamie Heath
Chief Scientific Officer
Richard Butt
Company Investors
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs